was read the article
array:21 [ "pii" => "S217357432030157X" "issn" => "21735743" "doi" => "10.1016/j.reumae.2020.11.001" "estado" => "S300" "fechaPublicacion" => "2021-01-01" "aid" => "1490" "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "prp" "cita" => "Reumatol Clin. 2021;17:59" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemAnterior" => array:18 [ "pii" => "S2173574320301611" "issn" => "21735743" "doi" => "10.1016/j.reumae.2018.12.014" "estado" => "S300" "fechaPublicacion" => "2021-01-01" "aid" => "1315" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2021;17:57-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Extension of the RENACER Study: 12-Month Efficacy, Safety and Certolizumab PEGol Survival in 501 Rheumatoid Arthritis Patients" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "57" "paginaFinal" => "58" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Ampliación del estudio RENACER: eficacia, seguridad y supervivencia a 12 meses de 501 pacientes de artritis reumatoide tratados con Certolizumab PEGol" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1367 "Ancho" => 1622 "Tamanyo" => 57536 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Comparative cumulative survival between bio-naïve patients and patients that received previous biological therapy.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Vicenç Torrente-Segarra, Manuel Fernández Prada, Rosa Expósito, Noemí Patricia Garrido Puñal, Amalia Sánchez-Andrade, José Ramón Lamúa-Riazuelo, Alejandro Olivé, Juan Víctor Tovar" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Vicenç" "apellidos" => "Torrente-Segarra" ] 1 => array:2 [ "nombre" => "Manuel" "apellidos" => "Fernández Prada" ] 2 => array:2 [ "nombre" => "Rosa" "apellidos" => "Expósito" ] 3 => array:2 [ "nombre" => "Noemí Patricia" "apellidos" => "Garrido Puñal" ] 4 => array:2 [ "nombre" => "Amalia" "apellidos" => "Sánchez-Andrade" ] 5 => array:2 [ "nombre" => "José Ramón" "apellidos" => "Lamúa-Riazuelo" ] 6 => array:2 [ "nombre" => "Alejandro" "apellidos" => "Olivé" ] 7 => array:2 [ "nombre" => "Juan Víctor" "apellidos" => "Tovar" ] 8 => array:1 [ "colaborador" => "on behalf of RENACER Study Group" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574320301611?idApp=UINPBA00004M" "url" => "/21735743/0000001700000001/v1_202101140856/S2173574320301611/v1_202101140856/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">In memoriam</span>" "titulo" => "Pere Barceló" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "59" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "José Vicente Moreno" "autores" => array:1 [ 0 => array:3 [ "nombre" => "José" "apellidos" => "Vicente Moreno" "email" => array:1 [ 0 => "dr.vicentemoreno@gmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Presidente de Honor de la SER" "identificador" => "aff0005" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall"><elsevierMultimedia ident="fig0005"></elsevierMultimedia></p><p id="par0010" class="elsevierStylePara elsevierViewall">Nos ha dejado Pere Barceló.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Pere Barceló has left us.</p><p id="par0020" class="elsevierStylePara elsevierViewall">He left too soon, surrounded by the love of his family and the affection and company of his friends.</p><p id="par0025" class="elsevierStylePara elsevierViewall">He was brilliant and charismatic. He combined intelligence, foresight, and practical sense with great management ability, which made all his initiatives successful.</p><p id="par0030" class="elsevierStylePara elsevierViewall">He was the youngest ever President of SER. With his drive he managed to inspire and attract highly valuable colleagues to his Project who were equally determined to make the Society a useful benchmark for Spanish rheumatology in its entirety. That Board laid the foundations of what we are now, providing the Society with scientific soundness and economic stability. In fact, 1992 was the first year in which our accounts were in surplus.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Professionally, he has left an indelible mark, devoting himself with the same brilliance to management and clinical practice, both in public and private medicine. In the former, he reorganised the rheumatology service at Vall d’Hebron hospital, making it one of the most important in Spain. In the private sphere, in addition to maintaining rheumatological care in the Clínica Platón, he created Reumatek and the rheumatology service of the Sagrat Cor hospital, where, until the end, he invested his entire capacity, experience and passion for medicine and patients.</p><p id="par0040" class="elsevierStylePara elsevierViewall">We have known each other almost from the very start of his professional activity at the National Centre for the Fight against Rheumatic Diseases (later the Hospital de Malalties Reumàtiques). Since then, we were always close and I followed him in some of his companies, enjoying a colleague, boss (in Vall d’Hebron) and in every situation, at work and outside it, a loyal friend and good man. Now, like all of us who were close to him, his loss leaves me with an intense and painful sense of emptiness.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Dear Pedro, every afternoon, in the clinic, I turn out lights that have been left on unnecessarily here and there, as you used to do. “It’s something I can’t stand” you used to say, half joking, half serious. The lights that you left on, initiative, responsibility, love of the specialty and work, devotion to patients… will not go out, because they are an example for everyone, and will always be with us, together with your memory.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Thank you for everything you have shared over so many years.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Pere Barceló. Reumatol Clin. 2021;17:61.</p>" ] ] "multimedia" => array:1 [ 0 => array:5 [ "identificador" => "fig0005" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 540 "Ancho" => 424 "Tamanyo" => 26895 ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001700000001/v1_202101140856/S217357432030157X/v1_202101140856/en/main.assets" "Apartado" => array:4 [ "identificador" => "8388" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "In memoriam" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001700000001/v1_202101140856/S217357432030157X/v1_202101140856/en/main.pdf?idApp=UINPBA00004M&text.app=https://www.reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357432030157X?idApp=UINPBA00004M" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 8 | 12 | 20 |
2024 September | 24 | 20 | 44 |
2024 August | 49 | 27 | 76 |
2024 July | 32 | 26 | 58 |
2024 June | 28 | 18 | 46 |
2024 May | 42 | 21 | 63 |
2024 April | 19 | 12 | 31 |
2024 March | 25 | 29 | 54 |
2024 February | 25 | 15 | 40 |
2024 January | 20 | 17 | 37 |
2023 December | 23 | 21 | 44 |
2023 November | 34 | 34 | 68 |
2023 October | 17 | 24 | 41 |
2023 September | 25 | 35 | 60 |
2023 August | 28 | 11 | 39 |
2023 July | 25 | 22 | 47 |
2023 June | 24 | 18 | 42 |
2023 May | 23 | 22 | 45 |
2023 April | 13 | 7 | 20 |
2023 March | 34 | 20 | 54 |
2023 February | 17 | 21 | 38 |
2023 January | 19 | 9 | 28 |
2022 December | 32 | 20 | 52 |
2022 November | 30 | 13 | 43 |
2022 October | 31 | 31 | 62 |
2022 September | 30 | 20 | 50 |
2022 August | 29 | 27 | 56 |
2022 July | 30 | 37 | 67 |
2022 June | 28 | 33 | 61 |
2022 May | 22 | 32 | 54 |
2022 April | 24 | 31 | 55 |
2022 March | 25 | 27 | 52 |
2022 February | 26 | 31 | 57 |
2022 January | 33 | 39 | 72 |
2021 December | 20 | 40 | 60 |
2021 November | 25 | 35 | 60 |
2021 October | 30 | 51 | 81 |
2021 September | 24 | 35 | 59 |
2021 August | 23 | 29 | 52 |
2021 July | 29 | 31 | 60 |